Tags

Type your tag names separated by a space and hit enter

Is lipid management effective for all stages of CKD?.
Blood Purif. 2013; 35(1-3):26-30.BP

Abstract

Patients with chronic kidney disease (CKD) suffer from high rates of cardiovascular morbidity and mortality. The general approach to traditional cardiovascular risk factor modification via dyslipidemia control has not been thoroughly tested in patients with all stages of CKD. In this article, we review the evidence for statin therapy in patients at various stages of CKD, including patients with CKD on dialysis and patients with kidney transplants.

Links

Publisher Full Text
karger.com?DOI=10.1159
karger.com?DOI=10.1159

Authors+Show Affiliations

Ku E
University of California San Francisco, San Francisco, CA, USA.
Campese V
No affiliation info available

MeSH

Cardiovascular DiseasesDyslipidemiasHumansHydroxymethylglutaryl-CoA Reductase InhibitorsKidney TransplantationLipidsRandomized Controlled Trials as TopicRenal DialysisRenal Insufficiency, ChronicRisk FactorsTreatment Outcome

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

23343543

Citation

Ku, Elaine, and Vito Campese. "Is Lipid Management Effective for All Stages of CKD?." Blood Purification, vol. 35, no. 1-3, 2013, pp. 26-30.
Ku E, Campese V. Is lipid management effective for all stages of CKD?. Blood Purif. 2013;35(1-3):26-30.
Ku, E., & Campese, V. (2013). Is lipid management effective for all stages of CKD?. Blood Purification, 35(1-3), 26-30. https://doi.org/10.1159/000345932
Ku E, Campese V. Is Lipid Management Effective for All Stages of CKD?. Blood Purif. 2013;35(1-3):26-30. PubMed PMID: 23343543.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Is lipid management effective for all stages of CKD?. AU - Ku,Elaine, AU - Campese,Vito, Y1 - 2013/01/22/ PY - 2013/1/25/entrez PY - 2013/1/25/pubmed PY - 2013/7/3/medline SP - 26 EP - 30 JF - Blood purification JO - Blood Purif VL - 35 IS - 1-3 N2 - Patients with chronic kidney disease (CKD) suffer from high rates of cardiovascular morbidity and mortality. The general approach to traditional cardiovascular risk factor modification via dyslipidemia control has not been thoroughly tested in patients with all stages of CKD. In this article, we review the evidence for statin therapy in patients at various stages of CKD, including patients with CKD on dialysis and patients with kidney transplants. SN - 1421-9735 UR - https://www.unboundmedicine.com/medline/citation/23343543/Is_lipid_management_effective_for_all_stages_of_CKD_ L2 - https://www.karger.com?DOI=10.1159/000345932 DB - PRIME DP - Unbound Medicine ER -